Skip to main content
RSC Advances logoLink to RSC Advances
. 2020 Apr 2;10(23):13552. doi: 10.1039/d0ra90029j

Correction: Paclitaxel prodrug based mixed micelles for tumor-targeted chemotherapy

Dongyang Tang 1, Xin Zhao 2, Tie Yang 3, Cheng Wang 4,
PMCID: PMC9128721  PMID: 35696122

Abstract

Correction for ‘Paclitaxel prodrug based mixed micelles for tumor-targeted chemotherapy’ by Dongyang Tang et al., RSC Adv., 2018, 8, 380–389.


The authors regret that in Fig. 4C, the image of the SM group with FA pretreatment was mistakenly a repeated version of the image of the SM group without FA pretreatment. The correct figure is included in this correction. This correction does not affect the scientific validity of the article.

Fig. 4. The in vitro cellular uptake analysis of SMs and MMs in the Hela cells. (A) The inverted fluorescence microscope images of the cells incubated with the C6-loaded SMs and MMs for 2 and 4 h. Scale bar: 200 μm. (B) Flow cytometric analysis of mean fluorescence intensity in the cells treated with the C6-loaded SMs and MMs for 2 and 4 h. (C) Inverted fluorescence microscope images of the cells incubated with the C6-loaded SMs and MMs with or without the FA pretreatment 4 h. Scale bar: 200 μm. The data are shown as mean ± S.D. (n = 3). (D) Flow cytometric analysis of mean fluorescence intensity in the cells treated with the C6-loaded SMs and MMs with or without the FA pretreatment 4 h.

Fig. 4

The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.

Supplementary Material


Articles from RSC Advances are provided here courtesy of Royal Society of Chemistry

RESOURCES